E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2018 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
DateTitle 
02/01/18Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
- Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016 - Fourth quarter diluted EPS of $1.82 on a reported basis, up 67.0% from 2016 primarily due to a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.40 on an adjusted basis excluding amortization, up 6.9% from 2016. Excess tax benefit associated with stock based compensation (ETB) benefited diluted EPS by $0.02 in the quarter and increased $0.01 compared to 2016. - Full year revenues of $7.71 billion, ... 
Printer Friendly Version
02/01/18Quest Diagnostics Completes Acquisition of MedXM
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will stren... 
Printer Friendly Version
01/30/18ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
Tenth time ChartMaxx honored with top industry ranking* Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management solution ranked number one among Document Management and Imaging (DMI) software products in the 2018 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information techno... 
Printer Friendly Version
01/23/18Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care
Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plans SECAUCUS, N.J., Jan. 23, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. ... 
Printer Friendly Version
01/19/18Quest Diagnostics To Release Fourth Quarter And Full Year 2017 Financial Results On February 1
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2017 results on Thursday, February 1, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dia... 
Printer Friendly Version
01/19/18Quest Diagnostics Named One of 2018 "World's Most Admired Companies" by Fortune Magazine for Third Consecutive Year
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2018 by Fortune for the third consecutive year.  The annual survey designated Quest Diagnostics as one of only five companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status.  The company advan... 
Printer Friendly Version
01/03/18Quest Diagnostics To Speak At The 36th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Jan. 3, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence.  The presentation is scheduled for Wednesday, January 10, 2018 at 12:... 
Printer Friendly Version